SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020

Eurosurveillance - Tập 25 Số 22 - 2020
Alexandre Bélot1, Denise Antona2, Sylvain Renolleau3, Étienne Javouhey3, Véronique Hentgen4, François Angoulvant4, Christophe Delacourt5, Xavier Iriart6, Caroline Ovaert6, Brigitte Bader‐Meunier7, Isabelle Koné‐Paut7, D Lévy-Brühl2
1Filière de santé des maladies auto-immunes et auto-inflammatoires rares (FAI2R), Lyon, France
2Santé Publique France, Agence nationale de Santé publique, Saint-Maurice cedex, France
3Groupe francophone de réanimation et d’urgences pédiatriques (GFRUP), Paris, France
4Groupe de pathologies infectieuses pédiatriques (GPIP), Nice, France
5Société Française de Pédiatrie (SFP), Paris, France
6Société Française de Cardiologie, filiale de Cardiologie pédiatrique et congénitale (FCPC), Paris, France
7Société francophone dédiée à l'étude des maladies inflammatoires pédiatriques (SOFREMIP), Paris, France

Tóm tắt

End of April 2020, French clinicians observed an increase in cases presenting with paediatric inflammatory multisystem syndrome (PIMS). Nationwide surveillance was set up and demonstrated temporospatial association with the coronavirus disease (COVID-19) epidemic for 156 reported cases as at 17 May: 108 were classified as confirmed (n = 79), probable (n = 16) or possible (n = 13) post-COVID-19 PIMS cases. A continuum of clinical features from Kawasaki-like disease to myocarditis was observed, requiring intensive care in 67% of cases.

Từ khóa


Tài liệu tham khảo

Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic., Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1

Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study., Lancet, 10.1016/S0140-6736(20)31103-X

World Health Organization (WHO). Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Geneva: WHO: 15 May 2020. Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19

Health Alert Network. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) CDCHAN-00432. Atlanta: Centers for Disease Control and Prevention; 14 May 2020. Available from: https://emergency.cdc.gov/han/2020/han00432.asp

Health Policy Team. Guidance - Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. London: Royal College of Paediatrics and Child Health. Available from: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 (accessed May 30, 2020).

European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Paediatric inflammatory multisystem syndrome and SARS -CoV-2 infection in children. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment

Turnier, 2015, Concurrent respiratory viruses and Kawasaki disease., Pediatrics, 136, e609, 10.1542/peds.2015-0950

Liu, 2020, Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease., Eur J Clin Invest, 50, 10.1111/eci.13210

Jamilloux, 2017, Geoepidemiology and immunologic features of autoinflammatory diseases: a comprehensive review., Clin Rev Allergy Immunol, 54, 454, 10.1007/s12016-017-8613-8

Casanova, 2020, A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection., Cell, 10.1016/j.cell.2020.05.016

Belhadjer, 2020, Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic., Circulation, 10.1161/CIRCULATIONAHA.120.048360

Toscano, 2020, Guillain-Barré Syndrome Associated with SARS-CoV-2., N Engl J Med, 10.1056/NEJMc2009191

Trouillet-Assant, 2020, Type I IFN immunoprofiling in COVID-19 patients., J Allergy Clin Immunol, 10.1016/j.jaci.2020.04.029

Thông tin
Thông tin xuất bản

Eurosurveillance

Tập 25 Số 22

Thông tin tác giả